Skip to main content
Equibles
EYPT logo

EYPT · EyePoint, Inc. · Metrics

Track EYPT — free

Use EYPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EYPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.23 -0.02 (-0.47%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$364.68M
Shares
86.21M

EYPT metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.23
Market cap
$364.68M

Price action

20 metrics
Price change (1W)
-7.6%
Price change (30D)
-68.6%
Price change (3M)
-67.5%
Price change (6M)
-68.0%
Price change (YTD)
-76.8%
Price change (1Y)
-68.3%
Trailing year
Price change (5Y)
-58.8%
52-week high
$18.85
52-week low
$4.23
Change from 52-week high
-77.6%
Change from 52-week low
+0.0%
Annualized volatility
96.8%
Annualized volatility (3M)
157.2%
Beta
1.1
RSI (14D)
28.3
Price vs SMA 50
-57.8%
Price vs SMA 200
-68.5%
Avg volume (3M)
3.42M
Relative volume
0.8
Average dollar volume
$26.65M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
86.21M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
130.8×
reciprocal yield 0.8%
P / book
2.2
reciprocal yield 45.6%
FCF yield
-74.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-84.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6.5×
reciprocal yield 15.4%
EV / revenue historical average (5Y)
6.5×
reciprocal yield 15.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-17

Profitability

9 metrics
Gross margin
—
Operating margin
-11,369.3%
Trailing 12 months
Net margin
-10,998.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$316.98M
Net income (TTM)
−$306.64M
Trailing 12 months
Diluted EPS (TTM)
$-3.75
FCF margin
-9,730.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.70

Growth

11 metrics
Revenue growth YoY
-90.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.79M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+23.8%
Year over year · more shares
Revenue CAGR (3Y)
-8.8%
Revenue CAGR (5Y)
-1.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-184.3%
Return on assets
-134.4%
Debt / equity
—
Current ratio
4.5
EBITDA (TTM)
−$314.38M
Free cash flow (TTM)
−$271.28M
Quick ratio
4.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$110.46M
Total assets
$228.19M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$267.30M
Capital expenditures (TTM)
$3.98M
R&D (TTM)
$262.73M
SG&A (TTM)
—
Stock compensation (TTM)
$35.21M
R&D / revenue
9,423.6%
Stock compensation / revenue
1,263.0%

Ownership (13F)

3 metrics
13F filers
193
13F filer change QoQ
0
Institutional ownership
112.8%

Short interest

3 metrics
Short interest
21.0%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
43 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$20,909
Insider-sentiment score
78 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1314102 CUSIP 30233G209 13F (30d) 77 filings 76 filers Visit website Investor relations